Two Adults with Adrenal Myelolipoma and 21-Hydroxylase Deficiency
Author(s) -
Ingrid Nermoen,
Ivar Følling,
Kjetil Vegge,
Arne Larmo,
Bjørn Gunnar Nedrebø,
Eystein S. Husebye,
Kristian Løvås
Publication year - 2009
Publication title -
case reports in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 20
eISSN - 1687-9627
pISSN - 1687-9635
DOI - 10.1155/2009/916891
Subject(s) - myelolipoma , medicine , congenital adrenal hyperplasia , 21 hydroxylase , differential diagnosis , adrenal gland , physiology , endocrinology , pathology , pediatrics
We present incidentally discovered adrenal myelolipomas in two adult males with untreated congenital adrenal hyperplasia (CAH). The patients had simple virilizing form of CAH due to mutations in the CYP21 gene coding for 21-hydroxylase; one was heterozygous for the I172N mutation and the other compound heterozygous for the I172N and I2splice mutations. The masses were not removed since myelolipomas are considered benign tumors, and the tumor size did not increase during four- and nine-year observation periods. An adrenal myelolipoma is an important exception to the rule that large tumours should be removed. Untreated CAH with prolonged excessive ACTH stimulation might contribute to the growth of adrenal masses. CAH should be considered as a differential diagnosis of patients with adrenal masses or adrenal myelolipomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom